10x Genomics, Inc.
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California. Show More...
-
Website http://www.10xgenomics.com
-
Sector Healthcare
-
Industry Health Information Services
-
Last Quote 9.53 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -0.23 -1.36 -0.8 -0.5 Dividends USD Payout Ratio % * Shares Mil 83.0 83.0 39.0 98.0 Book Value Per Share * USD 4.38 4.16 Free Cash Flow Per Share * USD -0.65 Return on Assets % -24.81 -112.53 -8.56 -7.99 Financial Leverage (Average) 1.44 1.49 Return on Equity % -31.24 -11.92 Return on Invested Capital % -23.93 -10.53 Interest Coverage -22.11 -45.66 -9.08 -14.79 Current Ratio 3.08 3.28 7.63 7.28 Quick Ratio 2.76 2.92 7.26 6.83 Debt/Equity 0.05 0.14